144 related articles for article (PubMed ID: 14965863)
1. Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillation.
Vink R; Van Den Brink RB; Levi M
Hematology; 2004 Feb; 9(1):1-9. PubMed ID: 14965863
[TBL] [Abstract][Full Text] [Related]
2. Challenges in managing anticoagulant therapy in patients with heart valve prostheses.
Vink R; Kamphuisen PW; van den Brink RB; Levi M
Expert Rev Cardiovasc Ther; 2007 May; 5(3):563-70. PubMed ID: 17489678
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves.
Chesebro JH; Adams PC; Fuster V
J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):41B-56B. PubMed ID: 3537070
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
Pengo V; De Caterina R
Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
[TBL] [Abstract][Full Text] [Related]
5. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
[TBL] [Abstract][Full Text] [Related]
6. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
7. Prevention of thromboembolic complications in patients with atrial fibrillation.
Spiezia L; Prandoni P
Minerva Cardioangiol; 2008 Dec; 56(6):643-52. PubMed ID: 19092739
[TBL] [Abstract][Full Text] [Related]
8. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
[TBL] [Abstract][Full Text] [Related]
9. Preventing thromboembolism in patients with prosthetic heart valves.
Turpie AG
Cardiol Clin; 1994 Aug; 12(3):487-93. PubMed ID: 7805081
[TBL] [Abstract][Full Text] [Related]
10. [Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism].
Vink R; van den Brink RB; Levi M
Ned Tijdschr Geneeskd; 2002 Nov; 146(48):2285-9. PubMed ID: 12497755
[TBL] [Abstract][Full Text] [Related]
11. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
[TBL] [Abstract][Full Text] [Related]
12. [Current recommendations for prevention of thromboembolism in patients with heart valve prostheses].
Gohlke-Bärwolf C
Z Kardiol; 2001; 90 Suppl 6():112-7. PubMed ID: 11826813
[TBL] [Abstract][Full Text] [Related]
13. Treatment of arterial thromboembolic disease.
Meyer BJ; Chesebro JH
Curr Opin Hematol; 1994 Sep; 1(5):336-40. PubMed ID: 9371302
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation in pregnancy.
Goland S; Elkayam U
Cardiol Clin; 2012 Aug; 30(3):395-405. PubMed ID: 22813365
[TBL] [Abstract][Full Text] [Related]
15. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
[TBL] [Abstract][Full Text] [Related]
16. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
King DE; Dickerson LM; Sack JL
Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
[TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in oral anticoagulation for atrial fibrillation.
Singh M; Adigopula S; Patel P; Kiran K; Khosla S
Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952
[TBL] [Abstract][Full Text] [Related]
19. [Indications of vitamin K antagonists and aspirin in the atrial fibrillation of the elderly].
Gentric A; Estivin S; Jestin C
Rev Med Interne; 2009 Aug; 30(8):671-7. PubMed ID: 19095331
[TBL] [Abstract][Full Text] [Related]
20. Aspirin--anticoagulant combination in patients with non valvular atrial fibrillation commentary on the FFAACS study results.
Lechat PP
Card Electrophysiol Rev; 2003 Dec; 7(4):372-3. PubMed ID: 15071257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
